Sign In
Buy BDSX
$16.10
+0.660 (+4.27%)
At Close: Jun 03, 2026
4 Stocks Insiders Are Buying
08:33am, Tuesday, 24'th Aug 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q2 2021 Results - Earnings Call Transcript
08:28pm, Tuesday, 10'th Aug 2021
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q2 2021 Results - Earnings Call Transcript
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
06:00am, Tuesday, 27'th Jul 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will r
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
04:01pm, Thursday, 17'th Jun 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. (NASDAQ: SEE
Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test
06:00am, Tuesday, 15'th Jun 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the broad comm
Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank
06:00am, Friday, 04'th Jun 2021
BOULDER, Colo. & SAN FRANCISCO--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading lung cancer diagnostic solutions company, announced a strategic partnership with Dat
BDSX Stock Price: Over 8% Increase Pre-Market Explanation
08:44am, Wednesday, 26'th May 2021
The stock price of Biodesix, Inc. (Nasdaq: BDSX) increased by over 8% pre-market. This is why it happened.
SAN CARLOS, Calif. and BOULDER, Colo.
Biodesix to Present at the William Blair 41st Annual Growth Stock Conference
06:00am, Tuesday, 25'th May 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q1 2021 Results - Earnings Call Transcript
09:36pm, Tuesday, 11'th May 2021
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q1 2021 Results - Earnings Call Transcript
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced in partnership
Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
06:00am, Monday, 26'th Apr 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will r
Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management
06:00am, Thursday, 22'nd Apr 2021
BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Pulmonary disease expert, Dr. Susan Garwood, is hosted by CHEST to discuss standardized risk assessment to inform lung nodule management
Biodesix Announces Fourth Quarter and Full Year 2020 Results
03:00pm, Tuesday, 16'th Mar 2021
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix releases fourth quarter and full year 2020 results
Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021
05:00am, Tuesday, 09'th Mar 2021
BOULDER, Colo.--(BUSINESS WIRE)-- #BDSX--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial
